(Q38099047)

28 August 2017

title

XIAP antisense therapy with AEG 35156 in acute myeloid leukemia (English)

1 reference

28 August 2017

3

Gautam Borthakur

1 reference

28 August 2017

author name string

Lakshmikanth Katragadda

series ordinal

1

1 reference

28 August 2017

Bing Z Carter

series ordinal

2

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 May 2013

1 reference

Expert Opinion on Investigational Drugs

28 August 2017

published in

1 reference

28 August 2017

volume

22

1 reference

28 August 2017

issue

5

1 reference

28 August 2017

page(s)

663-670

1 reference

Caspase-3 and inhibitor of apoptosis protein(s) interactions in Saccharomyces cerevisiae and mammalian cells

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

IAP proteins: blocking the road to death's door

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Expression of IAP-family proteins in adult acute mixed lineage leukemia (AMLL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Expression of IAP family proteins in myelodysplastic syndromes transforming to overt leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Overexpression of X-linked inhibitor of apoptosis protein (XIAP) is an independent unfavorable prognostic factor in childhood de novo acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Alterations in the apoptotic machinery and their potential role in anticancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Prognostic significance of XIAP expression in DLBCL and effect of its inhibition on AKT signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Expression of X-linked inhibitor of apoptosis protein in human colorectal cancer and its correlation with prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Targeting XIAP for the treatment of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Involvement of caspase-2 and caspase-9 in endoplasmic reticulum stress-induced apoptosis: a role for the IAPs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

XIAP Induces NF-κB Activation via the BIR1/TAB1 Interaction and BIR1 Dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

An IAP-IAP complex inhibits apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

The polypeptide chain-releasing factor GSPT1/eRF3 is proteolytically processed into an IAP-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Application of XIAP antisense to cancer and other proliferative disorders: development of AEG35156/ GEM640

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Regulation and targeting of antiapoptotic XIAP in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Small molecule XIAP inhibitors cooperate with TRAIL to induce apoptosis in childhood acute leukemia cells and overcome Bcl-2-mediated resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Phase I trial of AEG35156 administered as a 7-day and 3-day continuous intravenous infusion in patients with advanced refractory cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

XIAP antisense oligonucleotide (AEG35156) achieves target knockdown and induces apoptosis preferentially in CD34+38− cells in a phase 1/2 study of patients with relapsed/refractory AML

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Downregulation of XIAP expression in ovarian cancer cells induces cell death in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Characterization of XIAP-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Smac mimetics as new cancer therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

Targeting IAP proteins for therapeutic intervention in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

IKKbeta-mediated nuclear factor-kappaB activation attenuates smac mimetic-induced apoptosis in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.789498

10.1517/13543784.2013.789498

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference